Atreca, Inc.

Atreca, Inc.verified

BCEL

Price:

$0.09

Market Cap:

$3.57M

Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-101 product candidate reacts in vitro with a majority of human ovarian, non-small cell lung, colorectal, and breast cancer samples from multiple patients. It also developing APN-122597, a receptor tyrosine kinase that target tumor tissues; and ATRC-501/MAM01, that targets the circumsporozoite protein of Plasmodium falciparum for the treatment of malaria...[Read more]

Industry

Biotechnology

IPO Date

2019-06-20

Stock Exchange

NASDAQ

Ticker

BCEL

The Current Ratio as of December 2024 (TTM) for Atreca, Inc. (BCEL) is 1.58

According to Atreca, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.58. This represents a change of -55.07% compared to the average of 3.53 of the last 4 quarters.

Atreca, Inc. (BCEL) Historical Current Ratio (quarterly & annually)

How has BCEL Current Ratio performed in the past?

The mean historical Current Ratio of Atreca, Inc. over the last ten years is 14.31. The current 1.58 Current Ratio has changed 1.01% with respect to the historical average. Over the past ten years (40 quarters), BCEL's Current Ratio was at its highest in in the September 2020 quarter at 28.48. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

14.31

Median

12.98

Minimum

4.79

Maximum

25.70

Atreca, Inc. (BCEL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Atreca, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 120.47%

Maximum Annual Current Ratio = 25.70

Minimum Annual Increase = -49.37%

Minimum Annual Current Ratio = 4.79

Quarterly (TTM)
Annual
YearCurrent RatioChange
20224.79-33.87%
20217.24-49.37%
202014.30-35.46%
201922.16-13.75%
201825.70120.47%

Atreca, Inc. (BCEL) Average Current Ratio

How has BCEL Current Ratio performed in the past?

The current Current Ratio of Atreca, Inc. (BCEL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.78

5-year avg

14.84

10-year avg

14.31

Atreca, Inc. (BCEL) Current Ratio vs. Peers

How is BCEL’s Current Ratio compared to its peers?

Atreca, Inc.’s Current Ratio is less than Passage Bio, Inc. (5.15), less than Homology Medicines, Inc. (4.19), less than Stoke Therapeutics, Inc. (5.09), less than TCR2 Therapeutics Inc. (2.77), less than Revolution Medicines, Inc. (14.24), less than Black Diamond Therapeutics, Inc. (5.55), less than Harpoon Therapeutics, Inc. (1.89), less than Alector, Inc. (3.29),

Build a custom stock screener for Atreca, Inc. (BCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atreca, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atreca, Inc. (BCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atreca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Atreca, Inc.'s Current Ratio?

How is the Current Ratio calculated for Atreca, Inc. (BCEL)?

What is the highest Current Ratio for Atreca, Inc. (BCEL)?

What is the 3-year average Current Ratio for Atreca, Inc. (BCEL)?

What is the 5-year average Current Ratio for Atreca, Inc. (BCEL)?

How does the current Current Ratio for Atreca, Inc. (BCEL) compare to its historical average?